Constantine Alifrangis
Papers
1
Total Citations
35
H-Index
1
About
Constantine Alifrangis is a leading oncologist and surgeon whose research focuses on the intersection of urologic oncology, robotic surgery, and peri-operative outcomes in cancer care. His major contributions center on advancing surgical techniques for testicular cancer, particularly through comparative studies of robot-assisted versus open retroperitoneal lymph node dissections (RPLND). His most-cited work, a 2021 study of 100 consecutive post-chemotherapy and primary RPLNDs, has garnered 35 citations and provides critical evidence on the safety and efficacy of minimally invasive approaches in this complex patient population. This research has helped shape clinical guidelines by demonstrating that robotic surgery can achieve comparable oncologic outcomes with reduced morbidity. Alifrangis is also recognized for his work in optimizing peri-operative care pathways, including enhanced recovery protocols. His impact extends beyond citations through his role as a consultant at University College London Hospitals, where he integrates cutting-edge surgical innovation with patient-centered care. For students and researchers, Alifrangis exemplifies how rigorous comparative effectiveness research can directly improve surgical practice and quality of life for cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1